<DOC>
	<DOCNO>NCT01817569</DOCNO>
	<brief_summary>The purpose investigation describe general safety profile type II Diabetes Mellitus ( DM ) Japanese patient exenatide therapy real world medical practice .</brief_summary>
	<brief_title>Specific Clinical Experience Investigation Long-term Use Exenatide ( Byetta Subcutaneous Injection )</brief_title>
	<detailed_description>Specific Clinical Experience Investigation long-term use exenatide ( Byetta subcutaneous injection ) .</detailed_description>
	<mesh_term>Exenatide</mesh_term>
	<criteria>Patient diagnose Type 2 Diabetes Mellitus naive patient Byetta .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Diabetes Mellitus ( DM )</keyword>
	<keyword>Byetta</keyword>
	<keyword>Exenatide</keyword>
</DOC>